Literature DB >> 12508159

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.

Camlin Tierney1, Janet L Lathey, Cindy Christopherson, Daniel M Bettendorf, Richard T D'Aquila, Scott M Hammer, David A Katzenstein.   

Abstract

Human immunodeficiency virus (HIV) type 1 DNA assay data were obtained at baseline from 111 HIV-1-positive subjects who were treated with nucleosides. Higher baseline DNA level, HIV-1 RNA level, and infectious titer were comparably associated with an increased hazard of disease progression (each P<.03). Only DNA level was significantly associated with survival (adjusted hazard ratio for 1 log(10) higher level, 3.99; 95% confidence interval, 1.44-11.09; P=.008).

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12508159     DOI： 10.1086/345870

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  15 in total

1.  Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Authors:  Ingrid A Beck; Minyoung Jang; Jennifer McKernan-Mullin; Marta Bull; Thor Wagner; Sharon Huang; Lin-Ye Song; Sharon Nachman; Paul Krogstad; Susan H Eshleman; Andrew Wiznia; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-27       Impact factor: 2.205

Review 2.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Authors:  Véronique Avettand-Fènoël; Laurent Hocqueloux; Jade Ghosn; Antoine Cheret; Pierre Frange; Adeline Melard; Jean-Paul Viard; Christine Rouzioux
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.

Authors:  Loredana Sarmati; Saverio Giuseppe Parisi; Emanuele Nicastri; Gabriella d'Ettorre; Lucia Palmisano; Mauro Andreotti; Carolina Andreoni; Marina Giuliano; Francesca Gatti; Caterina Boldrin; Giorgio Palù; Vincenzo Vullo; Stefano Vella; Massimo Andreoni
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.

Authors:  Seble Kassaye; Elizabeth Johnston; Bryan McColgan; Rami Kantor; Lynn Zijenah; David Katzenstein
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

5.  Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Authors:  Alexander O Pasternak; Marlous L Grijsen; Ferdinand W Wit; Margreet Bakker; Suzanne Jurriaans; Jan M Prins; Ben Berkhout
Journal:  JCI Insight       Date:  2020-03-26

6.  Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe.

Authors:  Victoria L Demetriou; David A M C van de Vijver; Ioanna Kousiappa; Claudia Balotta; Bonaventura Clotet; Zehava Grossman; Louise B Jørgensen; Snjezana Z Lepej; Itzchak Levy; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Francois Roman; Lidia Ruiz; Jean-Claude Schmidt; Anne-Mieke Vandamme; Kristel Van Laethem; Jurgen Vercauteren; Leondios G Kostrikis
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

7.  Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA.

Authors:  A Beloukas; D Paraskevis; C Haida; V Sypsa; A Hatzakis
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

8.  Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.

Authors:  Gautam K Sahu; David Paar; Simon D W Frost; Melissa M Smith; Scott Weaver; Miles W Cloyd
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

9.  Different patterns of HIV-1 DNA after therapy discontinuation.

Authors:  Maria Carla Re; Francesca Vitone; Laura Sighinolfi; Pasqua Schiavone; Florio Ghinelli; Davide Gibellini
Journal:  BMC Infect Dis       Date:  2005-09-12       Impact factor: 3.090

10.  Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study.

Authors:  Powel Kazanjian; Wei Wei; Morton Brown; Tejal Gandhi; Kamal Amin
Journal:  J Transl Med       Date:  2005-10-31       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.